BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15805262)

  • 1. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
    Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
    Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
    Sulman EP; Dumanski JP; White PS; Zhao H; Maris JM; Mathiesen T; Bruder C; Cnaan A; Brodeur GM
    Cancer Res; 1998 Aug; 58(15):3226-30. PubMed ID: 9699646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
    Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
    Espinosa AB; Mackintosh C; Maíllo A; Gutierrez L; Sousa P; Merino M; Ortiz J; de Alava E; Orfao A; Tabernero MD
    Eur J Hum Genet; 2008 Dec; 16(12):1450-8. PubMed ID: 18628790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
    Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
    Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.
    Dumanski JP; Rouleau GA; Nordenskjöld M; Collins VP
    Cancer Res; 1990 Sep; 50(18):5863-7. PubMed ID: 2393856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
    Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
    Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
    BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.
    Mocker K; Holland H; Ahnert P; Schober R; Bauer M; Kirsten H; Koschny R; Meixensberger J; Krupp W
    Pathol Res Pract; 2011 Jan; 207(1):67-72. PubMed ID: 20926204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
    Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
    Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme.
    Díaz de Ståhl T; Hartmann C; de Bustos C; Piotrowski A; Benetkiewicz M; Mantripragada KK; Tykwinski T; von Deimling A; Dumanski JP
    Genes Chromosomes Cancer; 2005 Oct; 44(2):161-9. PubMed ID: 15945096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas.
    Martínez-Glez V; Alvarez L; Franco-Hernández C; Torres-Martin M; de Campos JM; Isla A; Vaquero J; Lassaletta L; Castresana JS; Casartelli C; Rey JA
    Cancer Genet Cytogenet; 2010 Jan; 196(1):1-6. PubMed ID: 19963129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogenetic aberrations in histologically benign infiltratively growing sphenoid wing meningiomas].
    Korshunov AG; Cherekaev VA; Bekiashev AKh; Sycheva RV
    Zh Vopr Neirokhir Im N N Burdenko; 2007; (4):11-5. PubMed ID: 18274131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.